Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.

Zadnik, Karla; Schulman, Erica; Flitcroft, Ian; Fogt, Jennifer S; Blumenfeld, Louis C; Fong, Tung M; Lang, Eric; Hemmati, Houman D; Chandler, Simon P

Zadnik, Karla; Schulman, Erica; Flitcroft, Ian; Fogt, Jennifer S; Blumenfeld, Louis C; Fong, Tung M; Lang, Eric; Hemmati, Houman D; Chandler, Simon P.

Afiliación

Zadnik K; The Ohio State University College of Optometry, Columbus.
Schulman E; SUNY College of Optometry, New York.
Flitcroft I; Centre for Eye Research, Dublin, Ireland.
Fogt JS; The Ohio State University College of Optometry, Columbus.
Blumenfeld LC; Eye Physicians of Central Florida, Maitland.
Fong TM; Vyluma Inc, Bridgewater, New Jersey.
Lang E; Vyluma Inc, Bridgewater, New Jersey.
Hemmati HD; Vyluma Inc, Bridgewater, New Jersey.
Chandler SP; Vyluma Inc, Bridgewater, New Jersey.

JAMA Ophthalmol ; 141(10): 990-999, 2023 Oct 01.

Article en En | MEDLINE | ID: mdl-37261839

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies / Risk_factors_studies Idioma: En Revista: JAMA Ophthalmol Año: 2023 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google